Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus in patients with autosomal dominant polycystic kidney disease.
Walz G, Budde K, Mannaa M, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hörl WH, Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Büchert M, May C, Gschaidmeier H, Kramer S, Eckardt KU. Walz G, et al. Among authors: arns w. N Engl J Med. 2010 Aug 26;363(9):830-40. doi: 10.1056/NEJMoa1003491. Epub 2010 Jun 26. N Engl J Med. 2010. PMID: 20581392 Free article. Clinical Trial.
Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies.
Varol H, Ernst A, Cristoferi I, Arns W, Baan CC, van Baardwijk M, van den Bosch T, Eckhoff J, Harth A, Hesselink DA, van Kemenade FJ, de Koning W, Kurschat C, Minnee RC, Mustafa DA, Reinders MEJ, Shahzad-Arshad SP, Snijders MLH, Stippel D, Stubbs AP, von der Thüsen J, Wirths K, Becker JU, Clahsen-van Groningen MC. Varol H, et al. Among authors: arns w. Transplantation. 2023 Apr 1;107(4):903-912. doi: 10.1097/TP.0000000000004372. Epub 2022 Oct 27. Transplantation. 2023. PMID: 36413151 Free PMC article.
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
Budde K, Glander P, Krämer BK, Fischer W, Hoffmann U, Bauer S, Grohmann J, Neumayer HH, Arns W. Budde K, et al. Among authors: arns w. Transplantation. 2007 Feb 27;83(4):417-24. doi: 10.1097/01.tp.0000251969.72691.ea. Transplantation. 2007. PMID: 17318074 Clinical Trial.
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
Krämer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuño J, Sester U, Kunzendorf U, Dietl KH, Bonomini V, Rigotti P, Ronco C, Tabernero JM, Rivero M, Banas B, Mühlbacher F, Arias M, Montagnino G; European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group. Krämer BK, et al. Nephrol Dial Transplant. 2008 Jul;23(7):2386-92. doi: 10.1093/ndt/gfn004. Epub 2008 Feb 7. Nephrol Dial Transplant. 2008. PMID: 18258740
Safety and efficacy of intensified versus standard dosing regimens of enteric-coated mycophenolate sodium in de novo renal transplant patients.
Sommerer C, Glander P, Arns W, Ariatabar T, Kramer S, Vogel EM, Shipkova M, Fischer W, Liefeldt L, Hackenberg R, Schmidt J, Zeier M, Budde K. Sommerer C, et al. Among authors: arns w. Transplantation. 2011 Apr 15;91(7):779-85. doi: 10.1097/TP.0b013e31820d3b9b. Transplantation. 2011. PMID: 21297553 Clinical Trial.
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
Budde K, Becker T, Arns W, Sommerer C, Reinke P, Eisenberger U, Kramer S, Fischer W, Gschaidmeier H, Pietruck F; ZEUS Study Investigators. Budde K, et al. Among authors: arns w. Lancet. 2011 Mar 5;377(9768):837-47. doi: 10.1016/S0140-6736(10)62318-5. Epub 2011 Feb 19. Lancet. 2011. PMID: 21334736 Clinical Trial.
103 results